Genzyme sues to stop Impax generic drug - San Francisco Business Times Print
San Francisco Business TimesGenzyme Corp. has filed a patent infringement suit against Impax Laboratories Inc. focused on the kidney dialysis drug Renvela. The Hayward-based generic ...Impax Laboratories Confirms Patent Challenge Relating to RENVELA(R), 2.4 g and

... read more